Scientist, IHC and Target Expression

PanTarg; København; On-site; DKK 650,000 - 900,000; Full time

Job summary

PanTarg is a Danish biotechnology company located on site at the BioInnovation Institute (BII) in Copenhagen. We are seeking a scientist with strong hands-on experience in immunohistochemistry (IHC) and target expression analyses to drive data generation for key readouts and business decisions.

The successful candidate will have a PhD and 3–5 years in pharma/biotech or as a postdoc, with additional in vitro biology and pharmacology experience desirable.

Qualifications

• PhD in a relevant field with 3–5 years of pharma/biotech/postdoc experience preferred.
• Experience in histology and IHC with target/biomarker scoring and tissue microarrays (TMA).
• Experience with tissue handling, sectioning and staining, ideally with digital image‑analysis software such as QuPath.
• Strong scientific communication skills and ability to present data to a professional audience.
• Fluent in English, written and spoken.

Responsibilities

• Generate and analyze data for key readouts and business decisions, including safety assessments and clinical indication selection.
• Perform histology and IHC experiments, scoring, and data interpretation.
• Maintain and optimize tissue handling, sectioning, and staining protocols; apply image analysis workflows.
• Collaborate with the CSO and team; clearly communicate results to stakeholders.

Skills

Histology & IHC

Biomarker scoring

Tissue microarrays (TMA)

Digital image analysis (QuPath)

Data interpretation & presentation

Education

PhD degree

Tools

QuPath

Job description

PanTarg is a Danish biotechnology company developing novel anti-cancer therapies in the form of antibody-drug conjugates (ADCs) for the treatment of aggressive cancers with high unmet medical need.

Our work is based on more than 30 years of research conducted at Rigshospitalet and University of Copenhagen, and our vision is to enable novel treatment options for cancer patients via a novel first-in-class approach to targeted therapy.

We are currently incubated at the BioInnovation Institute (BII), a Copenhagen-based incubation hub for biotech startups in Europe. Here, we are currently progressing through preclinical development, aiming to reach a stage of clinical testing within a few years.

The position

We are looking for a scientist to join our team on site at BII. We are primarily looking for a candidate with several years of hands‑on experience, especially within immunohistochemistry (IHC) techniques and target expression analyses. The candidate will be responsible for generating and analyzing data that will be essential for several key readouts and business decisions, including safety assessments and clinical indication selection.

Qualifications

• Primary qualification: Documented experience in histology and IHC, including target/biomarker scoring, tissue microarrays (TMA), and spatial analysis. Experience with tissue handling, sectioning, and staining is highly desirable, ideally combined with experience using digital image‑analysis software such as QuPath or equivalent.
• The optimal candidate will have obtained a PhD degree and have at least 3-5 years of experience from either pharma, biotech, or as a post doc. Robust and documented (5+ years) relevant hands‑on experience without a PhD degree may also be acceptable, if the primary qualification is met.
• Secondary qualification: Hands‑on experience with in vitro biology & pharmacology in the form of mammalian cell culture, in‑vitro dose‑response studies and characterization of drug activity, cell viability/cytotoxicity assays, flow cytometry, ELISA, and related cellular assays, will be a highly desired skillset.
• Good scientific communications skills, and the ability to clearly and precisely present data to a professional audience.
• Good interpersonal skills, and the ability to thrive in a startup environment where flexibility and a can‑do attitude is part of everyday work life.
• Fluent in the English language, written as well as spoken.

General information

• You will be reporting to the Chief Scientific Officer.
• The position is full time, and on-site presence at the BioInnovation Institute in Copenhagen will be required.
• Interviews will be conducted on an ongoing basis, and the selected candidate will start as soon as possible.
• Questions about the open position should be addressed to the e‑mail address [e-mail]